Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

MicroRNA-binding site polymorphisms and risk of colorectal cancer: A systematic review and meta-analysis

M. Gholami, B. Larijani, F. Sharifi, S. Hasani-Ranjbar, R. Taslimi, M. Bastami, R. Atlasi, MM. Amoli,

. 2019 ; 8 (17) : 7477-7499. [pub] 20191021

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, metaanalýza, práce podpořená grantem, systematický přehled

Perzistentní odkaz   https://www.medvik.cz/link/bmc20015861

Grantová podpora
1395-02-105-2087 Tehran University of Medical Sciences and Health Services - International

Genetic variations in miRNAs binding site might participate in cancer risk. This study aimed to systematically review the association between miRNA-binding site polymorphisms and colorectal cancer (CRC). Electronic literature search was carried out on PubMed, Web of Science (WOS), Scopus, and Embase. All types of observational studies till 30 November 2018 were included. Overall 85 studies (21 SNPs) from two systematic searches were included analysis. The results showed that in the Middle East population, the minor allele of rs731236 was associated with decreased risk of CRC (heterozygote model: 0.76 [0.61-0.95]). The minor allele of rs3025039 was related to increased risk of CRC in East Asian population (allelic model: 1.25 [1.01-1.54]). Results for rs3212986 were significant in overall and subgroup analysis (P < .05). For rs1801157 in subgroup analysis the association was significant in Asian populations (including allelic model: 2.28 [1.11-4.69]). For rs712, subgroup analysis revealed a significant (allelic model: 1.41 [1.23-1.61]) and borderline (allelic model: 0.92 [0.84-1.00]) association in Chinese and Czech populations, respectively. The minor allele of rs17281995 increased risk of CRC in different genetic models (P < .05). Finally, rs5275, rs4648298, and rs61764370 did not show significant associations. In conclusion, minor allele of rs3025039, rs3212986, and rs712 polymorphisms increases the risk of CRC in the East Asian population, and heterozygote model of rs731236 polymorphism shows protective effect in the Middle East population. In Europeans, the minor allele of rs17281995 may increase the risk of CRC, while rs712 may have a protective effect. Further analysis based on population stratifications should be considered in future studies.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20015861
003      
CZ-PrNML
005      
20201119104858.0
007      
ta
008      
201012s2019 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/cam4.2600 $2 doi
035    __
$a (PubMed)31637880
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Gholami, Morteza $u Obesity and Eating Habits Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
245    10
$a MicroRNA-binding site polymorphisms and risk of colorectal cancer: A systematic review and meta-analysis / $c M. Gholami, B. Larijani, F. Sharifi, S. Hasani-Ranjbar, R. Taslimi, M. Bastami, R. Atlasi, MM. Amoli,
520    9_
$a Genetic variations in miRNAs binding site might participate in cancer risk. This study aimed to systematically review the association between miRNA-binding site polymorphisms and colorectal cancer (CRC). Electronic literature search was carried out on PubMed, Web of Science (WOS), Scopus, and Embase. All types of observational studies till 30 November 2018 were included. Overall 85 studies (21 SNPs) from two systematic searches were included analysis. The results showed that in the Middle East population, the minor allele of rs731236 was associated with decreased risk of CRC (heterozygote model: 0.76 [0.61-0.95]). The minor allele of rs3025039 was related to increased risk of CRC in East Asian population (allelic model: 1.25 [1.01-1.54]). Results for rs3212986 were significant in overall and subgroup analysis (P < .05). For rs1801157 in subgroup analysis the association was significant in Asian populations (including allelic model: 2.28 [1.11-4.69]). For rs712, subgroup analysis revealed a significant (allelic model: 1.41 [1.23-1.61]) and borderline (allelic model: 0.92 [0.84-1.00]) association in Chinese and Czech populations, respectively. The minor allele of rs17281995 increased risk of CRC in different genetic models (P < .05). Finally, rs5275, rs4648298, and rs61764370 did not show significant associations. In conclusion, minor allele of rs3025039, rs3212986, and rs712 polymorphisms increases the risk of CRC in the East Asian population, and heterozygote model of rs731236 polymorphism shows protective effect in the Middle East population. In Europeans, the minor allele of rs17281995 may increase the risk of CRC, while rs712 may have a protective effect. Further analysis based on population stratifications should be considered in future studies.
650    _2
$a 3' nepřekládaná oblast $x genetika $7 D020413
650    _2
$a alely $7 D000483
650    _2
$a Asijci $x genetika $7 D044466
650    _2
$a vazebná místa $x genetika $7 D001665
650    _2
$a kolorektální nádory $x epidemiologie $x genetika $7 D015179
650    _2
$a regulace genové exprese u nádorů $7 D015972
650    12
$a genetická predispozice k nemoci $7 D020022
650    _2
$a lidé $7 D006801
650    _2
$a mikro RNA $x metabolismus $7 D035683
650    _2
$a pozorovací studie jako téma $7 D064887
650    _2
$a jednonukleotidový polymorfismus $7 D020641
650    _2
$a rizikové faktory $7 D012307
651    _2
$a Česká republika $x epidemiologie $7 D018153
651    _2
$a Dálný východ $x epidemiologie $7 D005202
651    _2
$a Střední východ $x epidemiologie $7 D008877
655    _2
$a časopisecké články $7 D016428
655    _2
$a metaanalýza $7 D017418
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a systematický přehled $7 D000078182
700    1_
$a Larijani, Bagher $u Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
700    1_
$a Sharifi, Farshad $u Elderly Health Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
700    1_
$a Hasani-Ranjbar, Shirin $u Obesity and Eating Habits Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
700    1_
$a Taslimi, Reza $u Department of Gastroenterology, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.
700    1_
$a Bastami, Milad $u Department of Medical Genetics, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
700    1_
$a Atlasi, Rasha $u Evidence Based Practice Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
700    1_
$a Amoli, Mahsa M $u Metabolic Disorders Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
773    0_
$w MED00181704 $t Cancer medicine $x 2045-7634 $g Roč. 8, č. 17 (2019), s. 7477-7499
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31637880 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201012 $b ABA008
991    __
$a 20201119104855 $b ABA008
999    __
$a ok $b bmc $g 1584288 $s 1106029
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 8 $c 17 $d 7477-7499 $e 20191021 $i 2045-7634 $m Cancer medicine $n Cancer Med $x MED00181704
GRA    __
$a 1395-02-105-2087 $p Tehran University of Medical Sciences and Health Services $2 International
LZP    __
$a Pubmed-20201012

Najít záznam

Citační ukazatele

Možnosti archivace